2
RESEARCH METHODOLOGY
33
5
MARKET OVERVIEW
Rising HPV cases drive cervical cancer market growth, fueled by increased screening awareness and R&D funding.
56
5.2.1.1
RISING HPV CASES AND SUBSEQUENT INCREASE IN CERVICAL CANCER
5.2.1.2
GROWING AWARENESS ABOUT CERVICAL CANCER SCREENING PROGRAMS
5.2.1.3
INCREASING R&D FUNDING INITIATIVES ON CERVICAL CANCER PREVENTION
5.2.2.1
GROWING AWARENESS AND ADOPTION OF HPV VACCINATION
5.2.3.1
REGULATORY GUIDELINES FOR CERVICAL CANCER SCREENING
5.2.3.2
INNOVATIVE IMPROVEMENTS IN HPV TESTS
5.2.4.1
UNCERTAIN REIMBURSEMENT SCENARIO
5.2.4.2
STRINGENT REGULATORY AND LEGAL REQUIREMENTS
5.2.4.3
OPERATIONAL BARRIERS
5.3
TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
5.4.1
AVERAGE SELLING PRICE TREND OF HPV AND PAP TESTS
5.4.2
AVERAGE SELLING PRICE TREND, BY KEY PLAYER
5.4.3
AVERAGE SELLING PRICE TREND, BY REGION
5.6
SUPPLY CHAIN ANALYSIS
5.8
INVESTMENT AND FUNDING SCENARIO
5.9.1.1
MOLECULAR DIAGNOSTICS
5.9.2
COMPLEMENTARY TECHNOLOGIES
5.9.3
ADJACENT TECHNOLOGIES
5.9.3.1
IMMUNODIAGNOSTICS
5.10
KEY CONFERENCES AND EVENTS, 2025–2026
5.12.1
IMPORT DATA FOR HS CODE 3822
5.12.2
EXPORT DATA FOR HS CODE 3822
5.13.1
CASE STUDY 1: UTILIZATION OF HUMAN PAPILLOMAVIRUS TESTING FOR CERVICAL CANCER SCREENING IN THAILAND
5.13.2
CASE STUDY 2: IMPLEMENTATION OF HUMAN PAPILLOMAVIRUS PRIMARY SCREENING OF CERVICAL CANCER IN BRITISH COLUMBIA
5.13.3
CASE STUDY 3: COMPARATIVE EVALUATION OF HPV SELF-SAMPLING IN INDIA
5.14
REGULATORY LANDSCAPE
5.14.1
REGULATORY FRAMEWORK
5.14.2
REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.15
PORTER’S FIVE FORCES ANALYSIS
5.15.1
BARGAINING POWER OF BUYERS
5.15.2
BARGAINING POWER OF SUPPLIERS
5.15.3
THREAT OF NEW ENTRANTS
5.15.4
THREAT OF SUBSTITUTES
5.15.5
INTENSITY OF COMPETITIVE RIVALRY
5.16
KEY STAKEHOLDERS AND BUYING CRITERIA
5.16.1
KEY STAKEHOLDERS IN BUYING PROCESS
5.17
IMPACT OF AI/GENERATIVE AI ON HPV TESTING AND PAP TEST MARKET
5.17.2
MARKET POTENTIAL OF AI
5.17.4
KEY COMPANIES IMPLEMENTING AI
5.17.5
FUTURE OF AI IN HPV TESTING AND PAP TEST MARKET
5.18
IMPACT OF 2025 US TARIFFS ON HPV TESTING AND PAP TEST MARKET
5.18.3
PRICE IMPACT ANALYSIS
5.18.4
IMPACT ON COUNTRY/REGION
5.18.5
IMPACT ON END-USE INDUSTRIES
5.18.5.2
DIAGNOSTIC LABORATORIES
5.18.5.3
PHYSICIANS’ OFFICES & CLINICS
6
HPV TESTING AND PAP TEST MARKET, BY PRODUCT & SERVICE
Market Size & Growth Rate Forecast Analysis to 2030 in USD Million | 6 Data Tables
96
6.2.1
RECURRENT PURCHASES OF ASSAYS & KITS TO DRIVE GROWTH
6.3.1
INCREASING ADOPTION OF AUTOMATED DIAGNOSTIC SYSTEMS TO DRIVE GROWTH
6.4.1
GROWING UPTAKE OF ADVANCED INSTRUMENTS TO DRIVE DEMAND
7
HPV TESTING AND PAP TEST MARKET, BY TEST TYPE
Market Size & Growth Rate Forecast Analysis to 2030 in USD Million | 34 Data Tables
102
7.2.1
PRIMARY HPV TESTING
7.2.1.1
TEST SENSITIVITY AND ACCURACY TO DRIVE GROWTH
7.2.2
FOLLOW-UP HPV TESTING
7.2.2.1
IRREGULAR PAP TEST RESULTS TO DRIVE ADOPTION
7.2.3.1
CO-TESTING TO DRIVE RAPID DETECTION RESULTS FOR CERVICAL CANCER
7.3.1
RISING CASES OF FALSE-NEGATIVE TESTS TO RESTRAIN MARKET
8
HPV TESTING AND PAP TEST MARKET, BY TECHNOLOGY
Market Size & Growth Rate Forecast Analysis to 2030 in USD Million | 21 Data Tables
117
8.2
MOLECULAR DIAGNOSTICS
8.2.1
HIGH SENSITIVITY AND SPECIFICITY IN HPV DETECTION TO DRIVE MARKET GROWTH
8.3.1
COST BENEFITS OF IMMUNOASSAYS TO BOOST DEMAND
8.4.1
AUTOMATION AND DIGITAL IMAGING TO DRIVE ADOPTION
9
HPV TESTING AND PAP TEST MARKET, BY APPLICATION
Market Size & Growth Rate Forecast Analysis to 2030 in USD Million | 15 Data Tables
127
9.2
CERVICAL CANCER SCREENING
9.2.1
RISING INCIDENCE OF CERVICAL CANCER TO DRIVE MARKET
9.3
VAGINAL CANCER SCREENING
9.3.1
LIMITED SCREENING TESTS TO RESTRAIN MARKET
10
HPV TESTING AND PAP TEST MARKET, BY CARE SETTING
Market Size & Growth Rate Forecast Analysis to 2030 in USD Million | 19 Data Tables
136
10.2.1
ADVANCED TECHNOLOGIES AND EQUIPPED FACILITIES TO DRIVE MARKET
10.3
DIAGNOSTIC LABORATORIES
10.3.1
INCREASING OUTSOURCING OF DIAGNOSTIC TESTS TO LABORATORIES TO DRIVE MARKET
10.4
PHYSICIANS’ OFFICES & CLINICS
10.4.1
RAPID AND EFFICIENT RESULTS TO SUPPORT MARKET GROWTH
11
HPV TESTING AND PAP TEST MARKET, BY REGION
Comprehensive coverage of 7 Regions with country-level deep-dive of 14 Countries | 133 Data Tables.
146
11.2.1
MACROECONOMIC OUTLOOK FOR NORTH AMERICA
11.2.2.1
RISING GOVERNMENT INITIATIVES FOR CERVICAL CANCER TESTING TO EXPEDITE GROWTH
11.2.3.1
GROWING AWARENESS OF CERVICAL CANCER SCREENING TO SUPPORT GROWTH
11.3.1
MACROECONOMIC OUTLOOK FOR EUROPE
11.3.2.1
ESTABLISHED HEALTHCARE INFRASTRUCTURE AND RISING HEALTHCARE SPENDING TO PROMOTE GROWTH
11.3.3.1
RISING FOCUS ON RESEARCH PROJECTS FOR SPECIFIC CANCERS TO CONTRIBUTE TO GROWTH
11.3.4.1
HIGH INCIDENCE OF CERVICAL CANCER AND ASSOCIATED INVESTMENTS IN GENOMICS TO STIMULATE GROWTH
11.3.5.1
GROWING ACCEPTANCE OF MOLECULAR-BASED DIAGNOSTIC TESTS FOR CERVICAL CANCER SCREENING TO BOOST MARKET
11.3.6.1
INCREASING RESEARCH ON CANCER DIAGNOSTICS TO ACCELERATE GROWTH
11.4.1
MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
11.4.2.1
GROWING PUBLIC ACCESS TO MODERN HEALTHCARE TO PROPEL MARKET
11.4.3.1
RISING DEMAND FOR TECHNOLOGICALLY ADVANCED CERVICAL CANCER SCREENING TESTS TO FACILITATE GROWTH
11.4.4.1
EXPANDING HEALTHCARE ACCESS AND HIGH CERVICAL CANCER BURDEN TO DRIVE MARKET
11.4.5
REST OF ASIA PACIFIC
11.5.1
MACROECONOMIC OUTLOOK FOR LATIN AMERICA
11.5.2.1
UNIVERSAL HEALTHCARE ACCESS TO SPEED UP GROWTH
11.5.3.1
IMPROVED ACCESS TO HEALTHCARE TO SUSTAIN GROWTH
11.5.4
REST OF LATIN AMERICA
11.6
MIDDLE EAST & AFRICA
11.6.1
MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
11.6.2.1
RISING GOVERNMENT HEALTHCARE EXPENDITURE TO AUGMENT GROWTH
11.6.3.1
INCREASING EMPHASIS ON HEALTHY LIFESTYLES AND QUALITY OF LIFE TO ENCOURAGE GROWTH
11.6.4
REST OF MIDDLE EAST & AFRICA
12
COMPETITIVE LANDSCAPE
Uncover key player strategies and market positions shaping the HPV and Pap test landscape.
210
12.2
KEY PLAYER STRATEGIES/RIGHT TO WIN
12.2.1
OVERVIEW OF MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN HPV TESTING AND PAP TEST MARKET
12.3
REVENUE ANALYSIS, 2022–2024
12.4
MARKET SHARE ANALYSIS, 2024
12.5
COMPANY VALUATION AND FINANCIAL METRICS
12.6
BRAND/PRODUCT COMPARISON
12.7
COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024
12.7.5
COMPANY FOOTPRINT: KEY PLAYERS, 2024
12.7.5.1
COMPANY FOOTPRINT
12.7.5.2
REGION FOOTPRINT
12.7.5.3
PRODUCT & SERVICE FOOTPRINT
12.7.5.4
TEST TYPE FOOTPRINT
12.7.5.5
TECHNOLOGY FOOTPRINT
12.8
COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024
12.8.1
PROGRESSIVE COMPANIES
12.8.2
RESPONSIVE COMPANIES
12.8.5
COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024
12.8.5.1
DETAILED LIST OF KEY STARTUPS/SMES
12.8.5.2
COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES
12.9
COMPETITIVE SCENARIO
12.9.1
PRODUCT LAUNCHES AND APPROVALS
13
COMPANY PROFILES
In-depth Company Profiles of Leading Market Players with detailed Business Overview, Product and Service Portfolio, Recent Developments, and Unique Analyst Perspective (MnM View)
229
13.1.1.1
BUSINESS OVERVIEW
13.1.1.2
PRODUCTS OFFERED
13.1.2
BECTON, DICKINSON AND COMPANY (BD)
13.1.3
F. HOFFMANN-LA ROCHE LTD.
13.1.5
DANAHER CORPORATION
13.1.8
SD BIOSENSOR, INC.
13.1.9
SANSURE BIOTECH INC.
13.1.10
ACON LABORATORIES, INC.
13.2.1
MOLBIO DIAGNOSTICS LIMITED
13.2.2
AB ANALITICA S.R.L.
13.2.5
TELLGEN CORPORATION
13.2.6
DAAN GENE CO., LTD.
13.2.7
JIANGSU BIOPERFECTUS TECHNOLOGIES CO., LTD.
13.2.8
ANATOLIA GENEWORKS
13.2.9
YANENG BIOSCIENCE (SHENZHEN) CO., LTD.
13.2.10
XIAMEN ZEESAN BIOTECH CO., LTD.
13.2.11
ADVANCED MOLECULAR DIAGNOSTICS (AMD)
13.2.12
MYLAB DISCOVERY SOLUTIONS PVT. LTD.
13.2.13
SACACE BIOTECHNOLOGIES SRL
13.2.14
JIANGSU MOLE BIOSCIENCE CO., LTD.
13.2.15
HANGZHOU ALLTEST BIOTECH CO., LTD.
13.2.16
HANGZHOU TONGZHOU BIOTECHNOLOGY CO., LTD.
13.2.17
NANJING LIMING BIOLOGICAL PRODUCTS CO., LTD.
14.2
KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
14.3
CUSTOMIZATION OPTIONS
TABLE 1
HPV TESTING AND PAP TEST MARKET: INCLUSIONS AND EXCLUSIONS
TABLE 2
HPV TESTING AND PAP TEST MARKET: KEY DATA FROM PRIMARY SOURCES
TABLE 3
HPV TESTING AND PAP TEST MARKET: RISK ASSESSMENT ANALYSIS
TABLE 4
ESTIMATED NUMBER OF NEW CASES OF CERVICAL CANCER, BY REGION, 2022 VS. 2030
TABLE 5
AVERAGE SELLING PRICING TREND OF HPV AND PAP TESTS, 2023–2025 (USD)
TABLE 6
AVERAGE SELLING PRICING TREND OF HPV AND PAP TESTS, BY REGION (USD)
TABLE 7
AVERAGE SELLING PRICE TREND OF HPV TESTS, BY KEY PLAYER, 2023–2025 (USD)
TABLE 8
AVERAGE SELLING PRICE TREND OF HPV TESTS, BY REGION, 2023–2025 (USD)
TABLE 9
HPV TESTING AND PAP TEST MARKET: ROLE OF COMPANIES IN ECOSYSTEM
TABLE 10
HPV TESTING AND PAP TEST MARKET: KEY CONFERENCES AND EVENTS, 2025–2026
TABLE 11
HPV TESTING AND PAP TEST MARKET: LIST OF MAJOR PATENTS, 2023–2025
TABLE 12
IMPORT DATA FOR HS CODE 3822-COMPLIANT PRODUCTS, BY COUNTRY, 2020–2024 (USD MILLION)
TABLE 13
EXPORT DATA FOR HS CODE 3822-COMPLIANT PRODUCTS, BY COUNTRY, 2020–2024 (USD MILLION)
TABLE 14
CLASSIFICATION OF IVD DEVICES IN EUROPE
TABLE 15
TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS IN JAPAN
TABLE 16
NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 17
EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 18
ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 19
LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 20
REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 21
HPV TESTING AND PAP TEST MARKET: IMPACT OF PORTER’S FIVE FORCES
TABLE 22
INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY PRODUCT & SERVICE (%)
TABLE 23
KEY BUYING CRITERIA, BY PRODUCT & SERVICE
TABLE 24
RECIPROCAL TARIFF RATES ADJUSTED BY US
TABLE 25
HPV TESTING AND PAP TEST MARKET, BY PRODUCT & SERVICE, 2023–2030 (USD MILLION)
TABLE 26
KEY CONSUMABLES AVAILABLE IN MARKET
TABLE 27
HPV TESTING AND PAP TEST CONSUMABLES MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 28
KEY INSTRUMENTS AVAILABLE IN MARKET
TABLE 29
HPV TESTING AND PAP TEST INSTRUMENTS MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 30
HPV TESTING AND PAP TEST SERVICES MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 31
HPV TESTING AND PAP TEST MARKET, BY TEST TYPE, 2023–2030 (USD MILLION)
TABLE 32
KEY HPV TESTING PRODUCTS AVAILABLE IN MARKET
TABLE 33
HPV TESTING MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 34
HPV TESTING MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 35
NORTH AMERICA: HPV TESTING MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 36
EUROPE: HPV TESTING MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 37
ASIA PACIFIC: HPV TESTING MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 38
LATIN AMERICA: HPV TESTING MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 39
MIDDLE EAST & AFRICA: HPV TESTING MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 40
PRIMARY HPV TESTING MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 41
NORTH AMERICA: PRIMARY HPV TESTING MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 42
EUROPE: PRIMARY HPV TESTING MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 43
ASIA PACIFIC: PRIMARY HPV TESTING MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 44
LATIN AMERICA: PRIMARY HPV TESTING MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 45
MIDDLE EAST & AFRICA: PRIMARY HPV TESTING MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 46
FOLLOW-UP HPV TESTING MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 47
NORTH AMERICA: FOLLOW-UP HPV TESTING MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 48
EUROPE: FOLLOW-UP HPV TESTING MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 49
ASIA PACIFIC: FOLLOW-UP HPV TESTING MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 50
LATIN AMERICA: FOLLOW-UP HPV TESTING MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 51
MIDDLE EAST & AFRICA: FOLLOW-UP HPV TESTING MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 52
CO-TESTING MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 53
NORTH AMERICA: CO-TESTING MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 54
EUROPE: CO-TESTING MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 55
ASIA PACIFIC: CO-TESTING MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 56
LATIN AMERICA: CO-TESTING MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 57
MIDDLE EAST & AFRICA: CO-TESTING MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 58
KEY PAP TESTS AVAILABLE IN MARKET
TABLE 59
PAP TESTS MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 60
NORTH AMERICA: PAP TESTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 61
EUROPE: PAP TESTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 62
ASIA PACIFIC: PAP TESTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 63
LATIN AMERICA: PAP TESTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 64
MIDDLE EAST & AFRICA: PAP TESTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 65
HPV TESTING AND PAP TEST MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
TABLE 66
KEY MOLECULAR DIAGNOSTIC-BASED PRODUCTS AVAILABLE IN MARKET
TABLE 67
HPV TESTING AND PAP TEST MARKET FOR MOLECULAR DIAGNOSTICS, BY REGION, 2023–2030 (USD MILLION)
TABLE 68
NORTH AMERICA: HPV TESTING AND PAP TEST MARKET FOR MOLECULAR DIAGNOSTICS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 69
EUROPE: HPV TESTING AND PAP TEST MARKET FOR MOLECULAR DIAGNOSTICS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 70
ASIA PACIFIC: HPV TESTING AND PAP TEST MARKET FOR MOLECULAR DIAGNOSTICS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 71
LATIN AMERICA: HPV TESTING AND PAP TEST MARKET FOR MOLECULAR DIAGNOSTICS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 72
MIDDLE EAST & AFRICA: HPV TESTING AND PAP TEST MARKET FOR MOLECULAR DIAGNOSTICS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 73
KEY IMMUNODIAGNOSTIC-BASED PRODUCTS AVAILABLE IN MARKET
TABLE 74
HPV TESTING AND PAP TEST MARKET FOR IMMUNODIAGNOSTICS, BY REGION, 2023–2030 (USD MILLION)
TABLE 75
NORTH AMERICA: HPV TESTING AND PAP TEST MARKET FOR IMMUNODIAGNOSTICS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 76
EUROPE: HPV TESTING AND PAP TEST MARKET FOR IMMUNODIAGNOSTICS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 77
ASIA PACIFIC: HPV TESTING AND PAP TEST MARKET FOR IMMUNODIAGNOSTICS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 78
LATIN AMERICA: HPV TESTING AND PAP TEST MARKET FOR IMMUNODIAGNOSTICS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 79
MIDDLE EAST & AFRICA: HPV TESTING AND PAP TEST MARKET FOR IMMUNODIAGNOSTICS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 80
HPV TESTING AND PAP TEST MARKET FOR CYTOLOGY, BY REGION, 2023–2030 (USD MILLION)
TABLE 81
NORTH AMERICA: HPV TESTING AND PAP TEST MARKET FOR CYTOLOGY, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 82
EUROPE: HPV TESTING AND PAP TEST MARKET FOR CYTOLOGY, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 83
ASIA PACIFIC: HPV TESTING AND PAP TEST MARKET FOR CYTOLOGY, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 84
LATIN AMERICA: HPV TESTING AND PAP TEST MARKET FOR CYTOLOGY, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 85
MIDDLE EAST & AFRICA: HPV TESTING AND PAP TEST MARKET FOR CYTOLOGY, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 86
HPV TESTING AND PAP TEST MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 87
KEY HPV TESTING AND PAP TESTS FOR CERVICAL CANCER SCREENING AVAILABLE IN MARKET
TABLE 88
HPV TESTING AND PAP TEST MARKET FOR CERVICAL CANCER SCREENING, BY REGION, 2023–2030 (USD MILLION)
TABLE 89
NORTH AMERICA: HPV TESTING AND PAP TEST MARKET FOR CERVICAL CANCER SCREENING, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 90
EUROPE: HPV TESTING AND PAP TEST MARKET FOR CERVICAL CANCER SCREENING, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 91
ASIA PACIFIC: HPV TESTING AND PAP TEST MARKET FOR CERVICAL CANCER SCREENING, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 92
LATIN AMERICA: HPV TESTING AND PAP TEST MARKET FOR CERVICAL CANCER SCREENING, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 93
MIDDLE EAST & AFRICA: HPV TESTING AND PAP TEST MARKET FOR CERVICAL CANCER SCREENING, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 94
KEY HPV TESTING AND PAP TESTS FOR VAGINAL CANCER SCREENING AVAILABLE IN MARKET
TABLE 95
HPV TESTING AND PAP TEST MARKET FOR VAGINAL CANCER SCREENING, BY REGION, 2023–2030 (USD MILLION)
TABLE 96
NORTH AMERICA: HPV TESTING AND PAP TEST MARKET FOR VAGINAL CANCER SCREENING, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 97
EUROPE: HPV TESTING AND PAP TEST MARKET FOR VAGINAL CANCER SCREENING, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 98
ASIA PACIFIC: HPV TESTING AND PAP TEST MARKET FOR VAGINAL CANCER SCREENING, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 99
LATIN AMERICA: HPV TESTING AND PAP TEST MARKET FOR VAGINAL CANCER SCREENING, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 100
MIDDLE EAST & AFRICA: HPV TESTING AND PAP TEST MARKET FOR VAGINAL CANCER SCREENING, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 101
HPV TESTING AND PAP TEST MARKET, BY CARE SETTING, 2023–2030 (USD MILLION)
TABLE 102
HPV TESTING AND PAP TEST MARKET FOR HOSPITALS, BY REGION, 2023–2030 (USD MILLION)
TABLE 103
NORTH AMERICA: HPV TESTING AND PAP TEST MARKET FOR HOSPITALS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 104
EUROPE: HPV TESTING AND PAP TEST MARKET FOR HOSPITALS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 105
ASIA PACIFIC: HPV TESTING AND PAP TEST MARKET FOR HOSPITALS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 106
LATIN AMERICA: HPV TESTING AND PAP TEST MARKET FOR HOSPITALS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 107
MIDDLE EAST & AFRICA: HPV TESTING AND PAP TEST MARKET FOR HOSPITALS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 108
HPV TESTING AND PAP TEST MARKET FOR DIAGNOSTIC LABORATORIES, BY REGION, 2023–2030 (USD MILLION)
TABLE 109
NORTH AMERICA: HPV TESTING AND PAP TEST MARKET FOR DIAGNOSTIC LABORATORIES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 110
EUROPE: HPV TESTING AND PAP TEST MARKET FOR DIAGNOSTIC LABORATORIES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 111
ASIA PACIFIC: HPV TESTING AND PAP TEST MARKET FOR DIAGNOSTIC LABORATORIES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 112
LATIN AMERICA: HPV TESTING AND PAP TEST MARKET FOR DIAGNOSTIC LABORATORIES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 113
MIDDLE EAST & AFRICA: HPV TESTING AND PAP TEST MARKET FOR DIAGNOSTIC LABORATORIES, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 114
HPV TESTING AND PAP TEST MARKET FOR PHYSICIANS’ OFFICES & CLINICS, BY REGION, 2023–2030 (USD MILLION)
TABLE 115
NORTH AMERICA: HPV TESTING AND PAP TEST MARKET FOR PHYSICIANS’ OFFICES & CLINICS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 116
EUROPE: HPV TESTING AND PAP TEST MARKET FOR PHYSICIANS’ OFFICES & CLINICS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 117
ASIA PACIFIC: HPV TESTING AND PAP TEST MARKET FOR PHYSICIANS’ OFFICES & CLINICS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 118
LATIN AMERICA: HPV TESTING AND PAP TEST MARKET FOR PHYSICIANS’ OFFICES & CLINICS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 119
MIDDLE EAST & AFRICA: HPV TESTING AND PAP TEST MARKET FOR PHYSICIANS’ OFFICES & CLINICS, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 120
PROJECTED CERVICAL CANCER CASES, BY COUNTRY, 2022 VS. 2030
TABLE 121
HPV TESTING AND PAP TEST MARKET, BY REGION, 2023–2030 (USD MILLION)
TABLE 122
TOTAL NUMBER OF HPV TESTS CONDUCTED, BY REGION, 2023–2030 (MILLION UNIT)
TABLE 123
TOTAL NUMBER OF PAP TESTS CONDUCTED, BY REGION, 2023–2030 (MILLION UNIT)
TABLE 124
NORTH AMERICA: KEY MACROECONOMIC INDICATORS
TABLE 125
NORTH AMERICA: HPV TESTING AND PAP TEST MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 126
NORTH AMERICA: HPV TESTING AND PAP TEST MARKET, BY PRODUCT & SERVICE, 2023–2030 (USD MILLION)
TABLE 127
NORTH AMERICA: HPV TESTING AND PAP TEST MARKET, BY TEST TYPE, 2023–2030 (USD MILLION)
TABLE 128
NORTH AMERICA: HPV TESTING MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 129
NORTH AMERICA: HPV TESTING AND PAP TEST MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
TABLE 130
NORTH AMERICA: HPV TESTING AND PAP TEST MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 131
NORTH AMERICA: HPV TESTING AND PAP TEST MARKET, BY CARE SETTING, 2023–2030 (USD MILLION)
TABLE 132
US: HPV TESTING AND PAP TEST MARKET, BY TEST TYPE, 2023–2030 (USD MILLION)
TABLE 133
US: HPV TESTING MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 134
US: HPV TESTING AND PAP TEST MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
TABLE 135
US: HPV TESTING AND PAP TEST MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 136
US: HPV TESTING AND PAP TEST MARKET, BY CARE SETTING, 2023–2030 (USD MILLION)
TABLE 137
CANADA: HPV TESTING AND PAP TEST MARKET, BY TEST TYPE, 2023–2030 (USD MILLION)
TABLE 138
CANADA: HPV TESTING MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 139
CANADA: HPV TESTING AND PAP TEST MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
TABLE 140
CANADA: HPV TESTING AND PAP TEST MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 141
CANADA: HPV TESTING AND PAP TEST MARKET, BY CARE SETTING, 2023–2030 (USD MILLION)
TABLE 142
EUROPE: HPV TESTING AND PAP TEST MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 143
EUROPE: HPV TESTING AND PAP TEST MARKET, BY PRODUCT & SERVICE, 2023–2030 (USD MILLION)
TABLE 144
EUROPE: HPV TESTING AND PAP TEST MARKET, BY TEST TYPE, 2023–2030 (USD MILLION)
TABLE 145
EUROPE: HPV TESTING MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 146
EUROPE: HPV TESTING AND PAP TEST MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
TABLE 147
EUROPE: HPV TESTING AND PAP TEST MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 148
EUROPE: HPV TESTING AND PAP TEST MARKET, BY CARE SETTING, 2023–2030 (USD MILLION)
TABLE 149
GERMANY: HPV TESTING AND PAP TEST MARKET, BY TEST TYPE, 2023–2030 (USD MILLION)
TABLE 150
GERMANY: HPV TESTING MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 151
GERMANY: HPV TESTING AND PAP TEST MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
TABLE 152
GERMANY: HPV TESTING AND PAP TEST MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 153
GERMANY: HPV TESTING AND PAP TEST MARKET, BY CARE SETTING, 2023–2030 (USD MILLION)
TABLE 154
UK: HPV TESTING AND PAP TEST MARKET, BY TEST TYPE, 2023–2030 (USD MILLION)
TABLE 155
UK: HPV TESTING MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 156
UK: HPV TESTING AND PAP TEST MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
TABLE 157
UK: HPV TESTING AND PAP TEST MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 158
UK: HPV TESTING AND PAP TEST MARKET, BY CARE SETTING, 2023–2030 (USD MILLION)
TABLE 159
FRANCE: HPV TESTING AND PAP TEST MARKET, BY TEST TYPE, 2023–2030 (USD MILLION)
TABLE 160
FRANCE: HPV TESTING MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 161
FRANCE: HPV TESTING AND PAP TEST MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
TABLE 162
FRANCE: HPV TESTING AND PAP TEST MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 163
FRANCE: HPV TESTING AND PAP TEST MARKET, BY CARE SETTING, 2023–2030 (USD MILLION)
TABLE 164
ITALY: HPV TESTING AND PAP TEST MARKET, BY TEST TYPE, 2023–2030 (USD MILLION)
TABLE 165
ITALY: HPV TESTING MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 166
ITALY: HPV TESTING AND PAP TEST MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
TABLE 167
ITALY: HPV TESTING AND PAP TEST MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 168
ITALY: HPV TESTING AND PAP TEST MARKET, BY CARE SETTING, 2023–2030 (USD MILLION)
TABLE 169
SPAIN: HPV TESTING AND PAP TEST MARKET, BY TEST TYPE, 2023–2030 (USD MILLION)
TABLE 170
SPAIN: HPV TESTING MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 171
SPAIN: HPV TESTING AND PAP TEST MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
TABLE 172
SPAIN: HPV TESTING AND PAP TEST MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 173
SPAIN: HPV TESTING AND PAP TEST MARKET, BY CARE SETTING, 2023–2030 (USD MILLION)
TABLE 174
REST OF EUROPE: HPV TESTING AND PAP TEST MARKET, BY TEST TYPE, 2023–2030 (USD MILLION)
TABLE 175
REST OF EUROPE: HPV TESTING MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 176
REST OF EUROPE: HPV TESTING AND PAP TEST MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
TABLE 177
REST OF EUROPE: HPV TESTING AND PAP TEST MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 178
REST OF EUROPE: HPV TESTING AND PAP TEST MARKET, BY CARE SETTING, 2023–2030 (USD MILLION)
TABLE 179
ASIA PACIFIC: KEY MACROECONOMIC INDICATORS
TABLE 180
ASIA PACIFIC: HPV TESTING AND PAP TEST MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 181
ASIA PACIFIC: HPV TESTING AND PAP TEST MARKET, BY PRODUCT & SERVICE, 2023–2030 (USD MILLION)
TABLE 182
ASIA PACIFIC: HPV TESTING AND PAP TEST MARKET, BY TEST TYPE, 2023–2030 (USD MILLION)
TABLE 183
ASIA PACIFIC: HPV TESTING MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 184
ASIA PACIFIC: HPV TESTING AND PAP TEST MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
TABLE 185
ASIA PACIFIC: HPV TESTING AND PAP TEST MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 186
ASIA PACIFIC: HPV TESTING AND PAP TEST MARKET, BY CARE SETTING, 2023–2030 (USD MILLION)
TABLE 187
CHINA: HPV TESTING AND PAP TEST MARKET, BY TEST TYPE, 2023–2030 (USD MILLION)
TABLE 188
CHINA: HPV TESTING MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 189
CHINA: HPV TESTING AND PAP TEST MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
TABLE 190
CHINA: HPV TESTING AND PAP TEST MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 191
CHINA: HPV TESTING AND PAP TEST MARKET, BY CARE SETTING, 2023–2030 (USD MILLION)
TABLE 192
JAPAN: HPV TESTING AND PAP TEST MARKET, BY TEST TYPE, 2023–2030 (USD MILLION)
TABLE 193
JAPAN: HPV TESTING MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 194
JAPAN: HPV TESTING AND PAP TEST MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
TABLE 195
JAPAN: HPV TESTING AND PAP TEST MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 196
JAPAN: HPV TESTING AND PAP TEST MARKET, BY CARE SETTING, 2023–2030 (USD MILLION)
TABLE 197
INDIA: HPV TESTING AND PAP TEST MARKET, BY TEST TYPE, 2023–2030 (USD MILLION)
TABLE 198
INDIA: HPV TESTING MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 199
INDIA: HPV TESTING AND PAP TEST MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
TABLE 200
INDIA: HPV TESTING AND PAP TEST MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 201
INDIA: HPV TESTING AND PAP TEST MARKET, BY CARE SETTING, 2023–2030 (USD MILLION)
TABLE 202
REST OF ASIA PACIFIC: HPV TESTING AND PAP TEST MARKET, BY TEST TYPE, 2023–2030 (USD MILLION)
TABLE 203
REST OF ASIA PACIFIC: HPV TESTING MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 204
REST OF ASIA PACIFIC: HPV TESTING AND PAP TEST MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
TABLE 205
REST OF ASIA PACIFIC: HPV TESTING AND PAP TEST MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 206
REST OF ASIA PACIFIC: HPV TESTING AND PAP TEST MARKET, BY CARE SETTING, 2023–2030 (USD MILLION)
TABLE 207
LATIN AMERICA: KEY MACROECONOMIC INDICATORS
TABLE 208
LATIN AMERICA: HPV TESTING AND PAP TEST MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 209
LATIN AMERICA: HPV TESTING AND PAP TEST MARKET, BY PRODUCT & SERVICE, 2023–2030 (USD MILLION)
TABLE 210
LATIN AMERICA: HPV TESTING AND PAP TEST MARKET, BY TEST TYPE, 2023–2030 (USD MILLION)
TABLE 211
LATIN AMERICA: HPV TESTING MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 212
LATIN AMERICA: HPV TESTING AND PAP TEST MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
TABLE 213
LATIN AMERICA: HPV TESTING AND PAP TEST MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 214
LATIN AMERICA: HPV TESTING AND PAP TEST MARKET, BY CARE SETTING, 2023–2030 (USD MILLION)
TABLE 215
BRAZIL: HPV TESTING AND PAP TEST MARKET, BY TEST TYPE, 2023–2030 (USD MILLION)
TABLE 216
BRAZIL: HPV TESTING MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 217
BRAZIL: HPV TESTING AND PAP TEST MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
TABLE 218
BRAZIL: HPV TESTING AND PAP TEST MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 219
BRAZIL: HPV TESTING AND PAP TEST MARKET, BY CARE SETTING, 2023–2030 (USD MILLION)
TABLE 220
MEXICO: HPV TESTING AND PAP TEST MARKET, BY TEST TYPE, 2023–2030 (USD MILLION)
TABLE 221
MEXICO: HPV TESTING MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 222
MEXICO: HPV TESTING AND PAP TEST MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
TABLE 223
MEXICO: HPV TESTING AND PAP TEST MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 224
MEXICO: HPV TESTING AND PAP TEST MARKET, BY CARE SETTING, 2023–2030 (USD MILLION)
TABLE 225
REST OF LATIN AMERICA: HPV TESTING AND PAP TEST MARKET, BY TEST TYPE, 2023–2030 (USD MILLION)
TABLE 226
REST OF LATIN AMERICA: HPV TESTING MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 227
REST OF LATIN AMERICA: HPV TESTING AND PAP TEST MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
TABLE 228
REST OF LATIN AMERICA: HPV TESTING AND PAP TEST MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 229
REST OF LATIN AMERICA: HPV TESTING AND PAP TEST MARKET, BY CARE SETTING, 2023–2030 (USD MILLION)
TABLE 230
MIDDLE EAST & AFRICA: KEY MACROECONOMIC INDICATORS
TABLE 231
MIDDLE EAST & AFRICA: HPV TESTING AND PAP TEST MARKET, BY COUNTRY, 2023–2030 (USD MILLION)
TABLE 232
MIDDLE EAST & AFRICA: HPV TESTING AND PAP TEST MARKET, BY PRODUCT & SERVICE, 2023–2030 (USD MILLION)
TABLE 233
MIDDLE EAST & AFRICA: HPV TESTING AND PAP TEST MARKET, BY TEST TYPE, 2023–2030 (USD MILLION)
TABLE 234
MIDDLE EAST & AFRICA: HPV TESTING MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 235
MIDDLE EAST & AFRICA: HPV TESTING AND PAP TEST MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
TABLE 236
MIDDLE EAST & AFRICA: HPV TESTING AND PAP TEST MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 237
MIDDLE EAST & AFRICA: HPV TESTING AND PAP TEST MARKET, BY CARE SETTING, 2023–2030 (USD MILLION)
TABLE 238
SAUDI ARABIA: HPV TESTING AND PAP TEST MARKET, BY TEST TYPE, 2023–2030 (USD MILLION)
TABLE 239
SAUDI ARABIA: HPV TESTING MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 240
SAUDI ARABIA: HPV TESTING AND PAP TEST MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
TABLE 241
SAUDI ARABIA: HPV TESTING AND PAP TEST MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 242
SAUDI ARABIA: HPV TESTING AND PAP TEST MARKET, BY CARE SETTING, 2023–2030 (USD MILLION)
TABLE 243
UAE: HPV TESTING AND PAP TEST MARKET, BY TEST TYPE, 2023–2030 (USD MILLION)
TABLE 244
UAE: HPV TESTING MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 245
UAE: HPV TESTING AND PAP TEST MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
TABLE 246
UAE: HPV TESTING AND PAP TEST MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 247
UAE: HPV TESTING AND PAP TEST MARKET, BY CARE SETTING, 2023–2030 (USD MILLION)
TABLE 248
REST OF MIDDLE EAST & AFRICA: HPV TESTING AND PAP TEST MARKET, BY TEST TYPE, 2023–2030 (USD MILLION)
TABLE 249
REST OF MIDDLE EAST & AFRICA: HPV TESTING MARKET, BY TYPE, 2023–2030 (USD MILLION)
TABLE 250
REST OF MIDDLE EAST & AFRICA: HPV TESTING AND PAP TEST MARKET, BY TECHNOLOGY, 2023–2030 (USD MILLION)
TABLE 251
REST OF MIDDLE EAST & AFRICA: HPV TESTING AND PAP TEST MARKET, BY APPLICATION, 2023–2030 (USD MILLION)
TABLE 252
REST OF MIDDLE EAST & AFRICA: HPV TESTING AND PAP TEST MARKET, BY CARE SETTING, 2023–2030 (USD MILLION)
TABLE 253
OVERVIEW OF MAJOR STRATEGIES DEPLOYED BY KEY PLAYERS IN HPV TESTING AND PAP TEST MARKET, JANUARY 2022−SEPTEMBER 2025
TABLE 254
HPV TESTING AND PAP TEST MARKET: DEGREE OF COMPETITION
TABLE 255
HPV TESTING AND PAP TEST MARKET: REGION FOOTPRINT
TABLE 256
HPV TESTING AND PAP TEST MARKET: PRODUCT & SERVICE FOOTPRINT
TABLE 257
HPV TESTING AND PAP TEST MARKET: TEST TYPE FOOTPRINT
TABLE 258
HPV TESTING AND PAP TEST MARKET: TECHNOLOGY FOOTPRINT
TABLE 259
HPV TESTING AND PAP TEST MARKET: DETAILED LIST OF KEY STARTUPS/SMES
TABLE 260
HPV TESTING AND PAP TEST MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES, BY PRODUCT & SERVICE AND TEST TYPE
TABLE 261
HPV TESTING AND PAP TEST MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES, BY REGION
TABLE 262
HPV TESTING AND PAP TEST MARKET: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2022–SEPTEMBER 2025
TABLE 263
HPV TESTING AND PAP TEST MARKET: DEALS, JANUARY 2022–SEPTEMBER 2025
TABLE 264
HPV TESTING AND PAP TEST MARKET: EXPANSIONS, JANUARY 2022–SEPTEMBER 2025
TABLE 265
HOLOGIC, INC.: COMPANY OVERVIEW
TABLE 266
HOLOGIC, INC.: PRODUCTS OFFERED
TABLE 267
BECTON, DICKINSON AND COMPANY (BD): COMPANY OVERVIEW
TABLE 268
BECTON, DICKINSON AND COMPANY (BD): PRODUCTS OFFERED
TABLE 269
BECTON, DICKINSON AND COMPANY (BD): PRODUCT LAUNCHES AND APPROVALS, JANUARY 2022–SEPTEMBER 2025
TABLE 270
BECTON, DICKINSON AND COMPANY (BD): DEALS, JANUARY 2022–SEPTEMBER 2025
TABLE 271
BECTON, DICKINSON AND COMPANY (BD): EXPANSIONS, JANUARY 2022–SEPTEMBER 2025
TABLE 272
F. HOFFMANN-LA ROCHE LTD.: COMPANY OVERVIEW
TABLE 273
F. HOFFMANN-LA ROCHE LTD.: PRODUCTS OFFERED
TABLE 274
F. HOFFMAN-LA ROCHE LTD.: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2022–SEPTEMBER 2025
TABLE 275
QIAGEN: COMPANY OVERVIEW
TABLE 276
QIAGEN: PRODUCTS OFFERED
TABLE 277
QIAGEN: EXPANSIONS, JANUARY 2022–SEPTEMBER 2025
TABLE 278
DANAHER CORPORATION: COMPANY OVERVIEW
TABLE 279
DANAHER CORPORATION: PRODUCTS OFFERED
TABLE 280
ABBOTT: COMPANY OVERVIEW
TABLE 281
ABBOTT: PRODUCTS OFFERED
TABLE 282
ABBOTT: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2022–SEPTEMBER 2025
TABLE 283
ABBOTT: DEALS, JANUARY 2022–SEPTEMBER 2025
TABLE 284
SEEGENE INC.: COMPANY OVERVIEW
TABLE 285
SEEGENE INC.: PRODUCTS OFFERED
TABLE 286
SEEGENE INC.: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2022–SEPTEMBER 2025
TABLE 287
SEEGENE INC.: DEALS, JANUARY 2022–SEPTEMBER 2025
TABLE 288
SD BIOSENSOR, INC.: COMPANY OVERVIEW
TABLE 289
SD BIOSENSOR, INC.: PRODUCTS OFFERED
TABLE 290
SANSURE BIOTECH INC.: COMPANY OVERVIEW
TABLE 291
SANSURE BIOTECH INC.: PRODUCTS OFFERED
TABLE 292
SANSURE BIOTECH INC.: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2022–SEPTEMBER 2025
TABLE 293
SANSURE BIOTECH INC.: DEALS, JANUARY 2022–SEPTEMBER 2025
TABLE 294
ACON LABORATORIES, INC.: COMPANY OVERVIEW
TABLE 295
ACON LABORATORIES, INC.: PRODUCTS OFFERED
TABLE 296
MOLBIO DIAGNOSTICS LIMITED: COMPANY OVERVIEW
TABLE 297
AB ANALITICA S.R.L.: COMPANY OVERVIEW
TABLE 298
CERTEST BIOTEC: COMPANY OVERVIEW
TABLE 299
ATILA BIOSYSTEMS: COMPANY OVERVIEW
TABLE 300
TELLGEN CORPORATION: COMPANY OVERVIEW
TABLE 301
DAAN GENE CO., LTD.: COMPANY OVERVIEW
TABLE 302
JIANGSU BIOPERFECTUS TECHNOLOGIES CO., LTD.: COMPANY OVERVIEW
TABLE 303
ANATOLIA GENEWORKS: COMPANY OVERVIEW
TABLE 304
YANENG BIOSCIENCE (SHENZHEN) CO., LTD.: COMPANY OVERVIEW
TABLE 305
XIAMEN ZEESAN BIOTECH CO., LTD.: COMPANY OVERVIEW
TABLE 306
ADVANCED MOLECULAR DIAGNOSTICS (AMD): COMPANY OVERVIEW
TABLE 307
MYLAB DISCOVERY SOLUTIONS PVT. LTD.: COMPANY OVERVIEW
TABLE 308
SACACE BIOTECHNOLOGIES SRL: COMPANY OVERVIEW
TABLE 309
JIANGSU MOLE BIOSCIENCE CO., LTD.: COMPANY OVERVIEW
TABLE 310
HANGZHOU ALLTEST BIOTECH CO., LTD.: COMPANY OVERVIEW
TABLE 311
HANGZHOU TONGZHOU BIOTECHNOLOGY CO., LTD.: COMPANY OVERVIEW
TABLE 312
NANJING LIMING BIOLOGICAL PRODUCTS CO., LTD.: COMPANY OVERVIEW
FIGURE 1
HPV TESTING AND PAP TEST MARKET SEGMENTATION AND REGIONAL SCOPE
FIGURE 2
HPV TESTING AND PAP TEST MARKET: RESEARCH DESIGN METHODOLOGY
FIGURE 4
KEY INDUSTRY INSIGHTS
FIGURE 5
BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
FIGURE 6
BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
FIGURE 7
BOTTOM-UP APPROACH: COMPANY REVENUE ESTIMATION APPROACH
FIGURE 8
CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
FIGURE 9
EPIDEMIOLOGY-BASED TEST VOLUME ESTIMATION APPROACH
FIGURE 10
HPV TESTING AND PAP TEST MARKET: TOP-DOWN APPROACH
FIGURE 11
DATA TRIANGULATION METHODOLOGY
FIGURE 12
HPV TESTING AND PAP TEST MARKET: RESEARCH ASSUMPTIONS
FIGURE 13
HPV TESTING AND PAP TEST MARKET, BY PRODUCT & SERVICE, 2025 VS. 2030 (USD MILLION)
FIGURE 14
HPV TESTING AND PAP TEST MARKET, BY TEST TYPE, 2025 VS. 2030 (USD MILLION)
FIGURE 15
HPV TESTING AND PAP TEST MARKET, BY TECHNOLOGY, 2025 VS. 2030(USD MILLION)
FIGURE 16
HPV TESTING AND PAP TEST MARKET, BY APPLICATION, 2025 VS. 2030 (USD MILLION)
FIGURE 17
HPV TESTING AND PAP TEST MARKET, BY CARE SETTING, 2025 VS. 2030 (USD MILLION)
FIGURE 18
HPV TESTING AND PAP TEST MARKET, BY REGION, 2025 VS. 2030 (USD MILLION)
FIGURE 19
RISING CASES OF HPV AND INCREASING R&D INITIATIVES ON CERVICAL CANCER SCREENING TO DRIVE MARKET
FIGURE 20
CONSUMABLES SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD
FIGURE 21
HPV TESTING SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD
FIGURE 22
MOLECULAR DIAGNOSTICS SEGMENT TO SHOWCASE LARGEST MARKET SHARE DURING FORECAST PERIOD
FIGURE 23
CERVICAL CANCER SCREENING SEGMENT TO ACCOUNT FOR LARGEST MARKET SHARE DURING FORECAST PERIOD
FIGURE 24
HOSPITALS SEGMENT TO CONTINUE TO DOMINATE MARKET IN 2030
FIGURE 25
NORTH AMERICAN MARKET TO ACCOUNT FOR LARGEST SHARE DURING FORECAST PERIOD
FIGURE 26
HPV TESTING AND PAP TEST MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
FIGURE 27
NEW REVENUE POCKETS FOR PLAYERS IN HPV TESTING AND PAP TEST MARKET
FIGURE 28
HPV TESTING AND PAP TEST MARKET: VALUE CHAIN ANALYSIS
FIGURE 29
HPV TESTING AND PAP TEST MARKET: SUPPLY CHAIN ANALYSIS
FIGURE 30
HPV TESTING AND PAP TEST MARKET: ECOSYSTEM ANALYSIS
FIGURE 31
HPV TESTING AND PAP TEST MARKET: INVESTMENT AND FUNDING SCENARIO, 2022–2025
FIGURE 32
HPV TESTING AND PAP TEST MARKET: PATENT ANALYSIS, JANUARY 2015–DECEMBER 2024
FIGURE 33
HPV TESTING AND PAP TEST MARKET: PORTER’S FIVE FORCES ANALYSIS
FIGURE 34
INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY PRODUCT & SERVICE
FIGURE 35
KEY BUYING CRITERIA, BY PRODUCT & SERVICE
FIGURE 36
MARKET POTENTIAL OF AI IN HPV TESTING AND PAP TEST MARKET
FIGURE 37
NORTH AMERICA: HPV TESTING AND PAP TEST MARKET SNAPSHOT
FIGURE 38
ASIA PACIFIC: HPV TESTING AND PAP TEST MARKET SNAPSHOT
FIGURE 39
REVENUE ANALYSIS OF KEY PLAYERS IN HPV TESTING AND PAP TEST MARKET, 2022–2024
FIGURE 40
MARKET SHARE ANALYSIS OF KEY PLAYERS IN HPV TESTING AND PAP TEST MARKET, 2024
FIGURE 41
YEAR-TO-DATE (YTD) PRICE, TOTAL RETURN, AND 5-YEAR STOCK BETA OF KEY VENDORS
FIGURE 42
EV/EBITDA OF KEY VENDORS
FIGURE 43
HPV TESTING AND PAP TEST MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS
FIGURE 44
HPV TESTING AND PAP TEST MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024
FIGURE 45
HPV TESTING AND PAP TEST MARKET: COMPANY FOOTPRINT
FIGURE 46
HPV TESTING AND PAP TEST MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024
FIGURE 47
HOLOGIC, INC.: COMPANY SNAPSHOT
FIGURE 48
BECTON, DICKINSON AND COMPANY (BD): COMPANY SNAPSHOT
FIGURE 49
F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT
FIGURE 50
QIAGEN: COMPANY SNAPSHOT
FIGURE 51
DANAHER CORPORATION: COMPANY SNAPSHOT
FIGURE 52
ABBOTT: COMPANY SNAPSHOT
FIGURE 53
SEEGENE INC.: COMPANY SNAPSHOT
FIGURE 54
SD BIOSENSOR, INC.: COMPANY SNAPSHOT
Growth opportunities and latent adjacency in Human Papilloma Virus/HPV Test and Pap Smear/Test Market